Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
Bonet C, Luciani F, Ottavi JF, Leclerc J, Jouenne FM, Boncompagni M, Bille K, Hofman V, Bossis G, Marco de Donatis G, Strub T, Cheli Y, Ohanna M, Luciano F, Marchetti S, Rocchi S, Birling MC, Avril MF, Poulalhon N, Luc T, Hofman P, Lacour JP, Davidson I, Bressac-de Paillerets B, Ballotti R, Marine JC, Bertolotto C. Bonet C, et al. Among authors: cheli y. J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw340. J Natl Cancer Inst. 2017. PMID: 28376192 Free article.
PGJ2 restores RA sensitivity in melanoma cells by decreasing PRAME and EZH2.
Pierron A, Le Pape E, Montaudié H, Castela E, De Donatis GM, Allegra M, Bertolotto C, Rocchi S, Cheli Y, Ballotti R, Passeron T. Pierron A, et al. Among authors: cheli y. J Dermatol Sci. 2014 Mar;73(3):258-61. doi: 10.1016/j.jdermsci.2013.11.003. Epub 2013 Nov 11. J Dermatol Sci. 2014. PMID: 24289988 No abstract available.
Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype.
Ohanna M, Cheli Y, Bonet C, Bonazzi VF, Allegra M, Giuliano S, Bille K, Bahadoran P, Giacchero D, Lacour JP, Boyle GM, Hayward NF, Bertolotto C, Ballotti R. Ohanna M, et al. Among authors: cheli y. Oncotarget. 2013 Dec;4(12):2212-24. doi: 10.18632/oncotarget.1143. Oncotarget. 2013. PMID: 24344100 Free PMC article.
CD271 is an imperfect marker for melanoma initiating cells.
Cheli Y, Bonnazi VF, Jacquel A, Allegra M, De Donatis GM, Bahadoran P, Bertolotto C, Ballotti R. Cheli Y, et al. Oncotarget. 2014 Jul 30;5(14):5272-83. doi: 10.18632/oncotarget.1967. Oncotarget. 2014. PMID: 25105565 Free PMC article.
36 results